Abstract
This chapter reviews the human immunodeficiency virus (HIV) pandemic and the broad spectrum of infectious, inflammatory, and neoplastic skin conditions that may occur in the setting of HIV-induced immune dysfunction. Because cutaneous manifestations often correlate with immune status, knowledge of a patient’s viral load and CD4+ T cell count can help generate a more focused differential diagnosis. HIV infection should be considered when patients present with severe, unusual, and treatment-resistant skin conditions; examples include giant molluscum contagiosum, extensive seborrheic dermatitis, and refractory herpes simplex virus infection. Following initiation of antiretroviral therapy (ART), skin disorders such as herpes zoster and non-tuberculous mycobacterial infection may become clinically apparent or worsen when the immune status improves, a phenomenon known as the immune reconstitution inflammatory syndrome (IRIS). Although ART has led to a reduction in the frequency of severe opportunistic infections and skin conditions associated with advanced HIV disease (e.g. Kaposi sarcoma), other dermatologic problems have become more common, including lipodystrophy and neoplasia related to human papillomavirus infection. In addition, the medications used in ART can cause drug eruptions.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.